0000899243-18-029166.txt : 20181116
0000899243-18-029166.hdr.sgml : 20181116
20181116173624
ACCESSION NUMBER: 0000899243-18-029166
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180712
FILED AS OF DATE: 20181116
DATE AS OF CHANGE: 20181116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Montgomery Alan Bruce
CENTRAL INDEX KEY: 0001313936
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-49908
FILM NUMBER: 181190802
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytoDyn Inc.
CENTRAL INDEX KEY: 0001175680
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 753056237
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
BUSINESS PHONE: 360-980-8524
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
FORMER COMPANY:
FORMER CONFORMED NAME: CYTODYN INC
DATE OF NAME CHANGE: 20031114
FORMER COMPANY:
FORMER CONFORMED NAME: REXRAY CORP
DATE OF NAME CHANGE: 20020617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-12
1
0001175680
CytoDyn Inc.
CYDY
0001313936
Montgomery Alan Bruce
1111 MAIN STREET, SUITE 660
VANCOUVER
WA
98660
1
0
0
0
Effective July 12, 2018, the reporting person is no longer a director in CytoDyn Inc (the "Company"). As a result, the reporting person is no longer subject to Section 16 in connection with its transactions in the equity securities of the Company, and therefore will no longer report any such transactions on Form 4 or Form 5.
/s/ Michael D. Mulholland, as attorney-in-fact
2018-11-16